title: [Prognostic factors in breast cancer patients].
authors.forename: I
authors.initials: I
authors.lastname: Roisman
authors.forename: T
authors.initials: T
authors.lastname: Peretz
authors.forename: A Z
authors.initials: AZ
authors.lastname: Reznick
authors.forename: I
authors.initials: I
authors.lastname: Lifshitz
authors.forename: A
authors.initials: A
authors.lastname: Bitterman
authors.forename: F
authors.initials: F
authors.lastname: Fares
authors.forename: H
authors.initials: H
authors.lastname: Toledano
authors.forename: A
authors.initials: A
authors.lastname: Barzilay
authors.forename: A L
authors.initials: AL
authors.lastname: Durst
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000473:pathology* / Q000628:therapy*; D002402:Cathepsin D / Q000032:analysis; D002882:Chromosomes, Human, Pair 13; D002886:Chromosomes, Human, Pair 17; D066246:ErbB Receptors / Q000032:analysis; D005260:Female; D005346:Fibroblast Growth Factors / Q000032:analysis; D006801:Humans; D011379:Prognosis; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis; D011960:Receptors, Estrogen / Q000032:analysis; D011980:Receptors, Progesterone / Q000032:analysis; D017481:Receptors, Somatostatin / Q000032:analysis; D016159:Tumor Suppressor Protein p53 / Q000032:analysis; D014568:Urokinase-Type Plasminogen Activator / Q000032:analysis
chemical_list: D014408:Biomarkers, Tumor; D002402:Cathepsin D; D066246:ErbB Receptors; D005346:Fibroblast Growth Factors; D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D017481:Receptors, Somatostatin; D016159:Tumor Suppressor Protein p53; D014568:Urokinase-Type Plasminogen Activator